FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:1380-1382 April 3, 2003 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Pitt, B. PubMed Citation

In the fall of 1999, a multicenter, randomized trial examining the effect of spironolactone on morbidity and mortality among patients with severe heart failure was published in the Journal.¹ The Randomized Aldactone Evaluation Study (RALES) proved that antagonism of aldosterone had an important role in the management of heart failure, even in patients taking angiotensin-converting–enzyme (ACE) inhibitors. In addition to reducing mortality by 30 percent, small doses of spironolactone resulted in an improvement in ventricular function and enhanced exercise tolerance.² The rates of death from progressive heart failure and sudden death from cardiac causes were both diminished by an . . . [Full Text of this Article]

Source Information

From the Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania, Philadelphia.

This article has been cited by other articles:

• van Kimmenade, R. R., Januzzi, J. L. Jr, Ellinor, P. T., Sharma, U. C., Bakker, J. A., Low, A. F., Martinez, A., Crijns, H. J., MacRae, C. A., Menheere, P. P., Pinto, Y. M. (2006). Utility of Amino-Terminal Pro-Brain Natriuretic Peptide, Galectin-3, and Apelin for the Evaluation of Patients With Acute Heart Failure. J Am Coll Cardiol 48: 1217-1224 [Abstract] [Full Text]  
• Silva, G. V., Litovsky, S., Assad, J. A.R., Sousa, A. L.S., Martin, B. J., Vela, D., Coulter, S. C., Lin, J., Ober, J., Vaughn, W. K., Branco, R. V.C., Oliveira, E. M., He, R., Geng, Y.-J., Willerson, J. T., Perin, E. C. (2005). Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model. Circulation 111: 150-156 [Abstract] [Full Text]  
• Cha, Y.-M., Redfield, M. M., Shen, W.-K., Gersh, B. J. (2004). Atrial Fibrillation and Ventricular Dysfunction: A Vicious Electromechanical Cycle. Circulation 109: 2839-2843 [Full Text]  
• (2003). Eplerenone Effective After MI in Patients with LVSD and Heart Failure. Journal Watch Cardiology 2003: 1-1 [Full Text]  
• (2003). Another Aldosterone Blocker Benefits Patients with LV Dysfunction. JWatch General 2003: 3-3 [Full Text]